India signs purchase order with Serum for AstraZeneca vaccine


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ India signs purchase order with Serum for AstraZeneca vaccine
India has signed a purchase order with vaccine producer Serum Institute to procure AstraZeneca’s COVID-19 vaccine, a source said on Monday, the first step in one of the world’s largest vaccination programs against the novel coronavirus.

India has signed a purchase order with vaccine producer Serum Institute to procure AstraZeneca’s COVID-19 vaccine, a source said on Monday, the first step in one of the world’s largest vaccination programs against the novel coronavirus.

Local television channel CNBC-TV 18 said the order was for 11 million doses and the government would buy the shots at 200 rupees ($2.72) per dose.

The government has also signed a purchase agreement with Indian firm Bharat Biotech for its COVID-19 vaccine, the news channel reported, citing unnamed sources.

Representatives for Serum, Bharat Biotech, and India’s health ministry did not immediately respond to Reuter's requests for comment.

India aims to secure 600 million doses for its vaccination drive that aims to inoculate 300 million citizens over the next six to eight months. The program is expected to begin on Jan. 16.

Serum, the world’s largest producer of vaccines, has stockpiled 50 million doses for immediate distribution.

India’s drug regulator had given emergency use approval for both vaccines earlier this month. Two other vaccines - Zydus Cadila’s ZyCoV-D and Russia’s Sputnik V - are still in trials in India.

Meanwhile, the government’s decision to approve the homegrown Bharat Biotech vaccine has met with criticism from health experts for the lack of data showing its efficacy.

At nearly 10.5 million, India has the world’s second-highest number of novel coronavirus infections behind the United States, although its rate of increase in cases has been slowing.

Story Source:- Reuters India.

Tags : #IndiasCovidUpdates11Jan #India #CovidVaccinePurchaseOrder #Covid-19Vaccine #AstraZeneca #SerumInstituteofIndia #worldslargestvaccinationdrive #AgainstNovelCoronaVirus #VaccinationTrial #IndiaFightAgainstVirus

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026